According to GlobalData’s medical device pipeline database, 74 Neurovascular Embolization Devices devices are in various stages of development globally. GlobalData’s report Neurovascular Embolization Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 54 are in active development, while the remaining 20 are in an inactive stage of development. There are 22 products in the early stages of development, and the remaining 32 are in the late stages of development.
Neurovascular embolization devices are used to treat abnormalities in blood vessels in the brain, namely, brain aneurysms and arteriovenous malformations (AVM). These devices occlude or prevent blood flow to unwanted vessel malformations. Aneurysm clips, liquid embolic systems, flow diversion stents, embolization coils and intrasaccular flow disruptors are tracked under this segment. One unit refers to one embolization device.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Neurovascular Embolization Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Neurovascular Embolization Devices devices. Overall, most of these Neurovascular Embolization Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Neurovascular Embolization Devices include Artio Medical, DePuy Synthes, Medtronic, MicroPort NeuroTech, Fluidx Medical Technology, Guichuangtongqiao Medical Technology, Integra LifeSciences, Peijia Medical, BioCure and eLUM Technologies.
For a complete picture of the developmental pipeline for Neurovascular Embolization Devices devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
